Team-based Interdisciplinary Cancer Research Training Program promoting horizontal and vertical interdisciplinary collaborations
Our Team-based Interdisciplinary Cancer Research Training (TICaRT) Program offers a unique training opportunity for pre- and postdoctoral trainees to develop interdisciplinary skills in cancer research and experience with transdisciplinary approaches.
Save the Date!
FRIDAY, Aug. 9, 2024
Annual TICaRT Research Symposium
The 2024 Team-based Interdisciplinary Cancer Research Training Program (TICaRT) Research Symposium will be held on Aug. 9 at the Cancer/Genetics Research Complex. Attendees can learn more about the program concept and hear from current trainees about their interdisciplinary team projects. The symposium will serve as an information session for faculty and trainees interested in participating in the program.
what makes us Unique
Interdisciplinary Teams
Horizontal & Vertical Collaborations
Near-Peer Mentoring
what we stand for
Objective
The objective of this T32 training program is to provide trainees from a broad range of disciplines the opportunity to develop interdisciplinary skills in cancer research and experience with transdisciplinary approaches.
Premise
Advances in the fundamental understanding of cancer and its clinical management rarely occur in isolation but typically represent team-based research endeavors.
Belief
Early exposure of trainees to interdisciplinary education and training coupled with team-based learning will better position them for successful cancer research careers.
TRAINEE SUCCESS
a meaningful path
Making an impact on cancer research
Daniel Stribling, who participated in the first cohort of the TICaRT program, has garnered numerous accolades for his research. Upon completion of the UF M.D.-Ph.D. program, he hopes to be part of applying the rapidly advancing fields of AI to genomics and medicine.
Contact
Contact
Questions? Please email education@cancer.ufl.edu for additional information.
Support
This program is supported with funding from the National Cancer Institute (Grant # T32 CA257923) and the University of Florida Health Cancer Center.